Active Pharmaceutical Ingredient (API)
Voglibose
Alpha-Glucosidase Inhibitor
An alpha-glucosidase inhibitor used to manage postprandial (after-meal) hyperglycemia in Type 2 Diabetes. It works by delaying the digestion and absorption of carbohydrates in the small intestine, leading to a flatter, lower rise in blood glucose levels. Its mechanism means its primary side effects are gastrointestinal (flatulence, abdominal discomfort).
Technical Profile
- Reference Code
- VOG045
- CAS Number
- 83480-29-9
- Chemical Class
- N/A
- Therapeutic Class
- N/A
Verified Brands
Medicines containing Voglibose as an active ingredient.
| Brand Name | Manufacturer | Formulation | MRP | |
|---|---|---|---|---|
| Vobose 0.2 OTC | USV Private Limited | Tablet (0.2 gm) | ₹115.00 | View Details |
| Voglibose 0.2 (Jan Aushadhi) OTC | Bureau of Pharma PSUs of India | Tablet (0.2 gm) | ₹21.00 | View Details |
| Volix 0.3 OTC | Sun Pharmaceutical Industries Ltd | Tablet (0.3 gm) | ₹155.00 | View Details |
| Voglibose 0.3 (Jan Aushadhi) OTC | Bureau of Pharma PSUs of India | Tablet (0.3 gm) | ₹28.00 | View Details |
| Voglistar-MD 0.2 OTC | Mankind Pharma Ltd | Tablet (0.2 gm) | ₹92.00 | View Details |
| Voglipack 0.2 OTC | Koye Pharmaceuticals Pvt Ltd | Tablet (0.2 gm) | ₹78.00 | View Details |